Neptune Technologies, Inc (NEPT) Covered Calls

Neptune Technologies & Bioressources Inc. researches, develops and commercializes bioactive ingredients and products with added-value and clinically proven health benefits.

You can sell covered calls on Neptune Technologies, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for NEPT (prices last updated Wed 4:16 PM ET):

Neptune Technologies, Inc (NEPT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
3.68 +0.01 3.66 3.74 741K - 0.3B
Covered Calls For Neptune Technologies, Inc (NEPT)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Mar 15 4 0.10 3.64 2.7% 41.1%
Apr 18 4 0.05 3.69 1.4% 8.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Neptune Technologies & Bioresources, Inc. is a biotechnology company engaged primarily in the development and commercialization of marine derived omega-3 polyunsaturated fatty acids. The company operates through three segments: Neptune, Acasti and NeuroBio. The Neptune segment involves the production and commercialization of nutraceutical products. The Acasti segment involves the development and commercialization of medical food and pharmaceutical products for cardiovascular diseases. The NeuroBio segment involves the development of medical food and pharmaceutical products for neurological diseases. Neptune Technologies & Bioresources was founded by Henri Harland on October 9, 1998 and is headquartered in Laval, Canada.